Combination motif immune stimulatory oligonucleotides with improved activity
    6.
    发明授权
    Combination motif immune stimulatory oligonucleotides with improved activity 失效
    具有改善活性的组合基序免疫刺激性寡核苷酸

    公开(公告)号:US08198251B2

    公开(公告)日:2012-06-12

    申请号:US12190402

    申请日:2008-08-12

    IPC分类号: A61K48/00

    摘要: Immunostimulatory oligonucleotides, which contain a CpG immunostimulatory motif and a second motif that is capable of forming secondary structure, including duplex and higher order structures in vitro and in vivo, are disclosed. They include nucleic acids, or pharmaceutically acceptable salts thereof, having base sequences that include 5′ TCGTCGTTTTCGGCGCGCGCCGT 3′ (SEQ ID NO: 1), in which each C is unmethylated and 3′ refers to the 3′ end of the nucleic acid. The oligonucleotides activate B cells and NK cells and induce expression of type I interferon and interferon-γ. The oligonucleotides are useful for treating a variety of disorders and conditions, including allergy, asthma, infection, and cancer. In addition to their use as single agents and as combination therapies, the disclosed oligonucleotides are useful as adjuvants in vaccines.

    摘要翻译: 公开了含有CpG免疫刺激基序和能够形成二级结构的第二基序的免疫刺激性寡核苷酸,包括体外和体内的双链体和高级结构。 它们包括具有碱基序列的核酸或其药学上可接受的盐,其包含5'TCGTCGTTTTCGGCGCGCGCCGT 3'(SEQ ID NO:1),其中每个C是未甲基化的,3'是指核酸的3'末端。 寡核苷酸激活B细胞和NK细胞并诱导I型干扰素和干扰素-γ的表达。 寡核苷酸可用于治疗各种疾病和病症,包括过敏,哮喘,感染和癌症。 除了它们作为单一药剂和联合疗法的用途之外,所公开的寡核苷酸可用作疫苗中的佐剂。

    COMBINATION MOTIF IMMUNE STIMULATORY OLIGONUCLEOTIDES WITH IMPROVED ACTIVITY
    8.
    发明申请
    COMBINATION MOTIF IMMUNE STIMULATORY OLIGONUCLEOTIDES WITH IMPROVED ACTIVITY 失效
    具有改善活性的组合动物免疫刺激性寡核苷酸

    公开(公告)号:US20090087446A1

    公开(公告)日:2009-04-02

    申请号:US12190402

    申请日:2008-08-12

    摘要: Immunostimulatory oligonucleotides, which contain a CpG immunostimulatory motif and a second motif that is capable of forming secondary structure, including duplex and higher order structures in vitro and in vivo, are disclosed. They include nucleic acids, or pharmaceutically acceptable salts thereof, having base sequences that include 5′ TCGTCGTTTTCGGCGCGCGCCGT 3′ (SEQ ID NO: 1), in which each C is unmethylated and 3′ refers to the 3′ end of the nucleic acid. The oligonucleotides activate B cells and NK cells and induce expression of type I interferon and interferon-γ. The oligonucleotides are useful for treating a variety of disorders and conditions, including allergy, asthma, infection, and cancer. In addition to their use as single agents and as combination therapies, the disclosed oligonucleotides are useful as adjuvants in vaccines.

    摘要翻译: 公开了含有CpG免疫刺激基序和能够形成二级结构的第二基序的免疫刺激性寡核苷酸,包括体外和体内的双链体和高级结构。 它们包括具有碱基序列的核酸或其药学上可接受的盐,其包含5'TCGTCGTTTTCGGCGCGCGCCGT 3'(SEQ ID NO:1),其中每个C是未甲基化的,3'是指核酸的3'末端。 寡核苷酸激活B细胞和NK细胞并诱导I型干扰素和干扰素-γ的表达。 寡核苷酸可用于治疗各种疾病和病症,包括过敏,哮喘,感染和癌症。 除了它们作为单一药剂和联合疗法的用途之外,所公开的寡核苷酸可用作疫苗中的佐剂。